-
Dissecting N-Type Calcium Channel Blockade by v-Agatoxin-IVA
2026-05-05
Sidach and Mintz (2000) clarified the low-affinity blockade of neuronal N-type calcium channels by the spider toxin v-agatoxin-IVA, revealing nuanced pharmacological selectivity among high-threshold Ca channel subtypes. These findings refine experimental approaches to distinguishing P-, Q-, and N-type channels, with significant implications for research into calcium-dependent signaling and secretion.
-
Primidone-Mediated TRPM3 Inhibition for Adenomyosis Pain Rel
2026-05-04
A recent study demonstrates that Primidone, traditionally known as an antiepileptic, inhibits TRPM3 channels and significantly reduces pain and myometrial infiltration in a mouse model of adenomyosis. This research highlights a mechanistically targeted, non-hormonal approach for managing adenomyosis symptoms and provides a framework for translational research focused on TRP channel modulation.
-
Amiloride (MK-870): Evidence-Based Sodium Channel Inhibition
2026-05-04
Amiloride (MK-870) is a validated inhibitor of epithelial sodium channels (ENaC) and urokinase-type plasminogen activator receptors (uPAR), widely used in sodium channel research. As supplied by APExBIO, it enables precise modulation of ion transport, cellular endocytosis, and epithelial physiology. Its robust efficacy and defined protocol parameters support research in cystic fibrosis, hypertension, and cellular signaling.
-
Structural Insights into Nipah Virus Polymerase Complex Func
2026-05-03
This study presents high-resolution structures of the Nipah virus L-P polymerase complex, elucidating the molecular architecture and key interactions essential for viral RNA synthesis. These insights lay critical groundwork for structure-based antiviral drug development targeting henipavirus replication machinery.
-
HOXC8 Suppresses Pyroptosis in NSCLC by Repressing Caspase-1
2026-05-02
This study uncovers that the transcription factor HOXC8 inhibits pyroptotic cell death in non-small cell lung carcinoma (NSCLC) by repressing caspase-1 expression via HDAC1/2 recruitment to the CASP1 promoter. These findings reveal a novel tumorigenic mechanism and suggest new avenues for modulating cell death pathways in cancer research.
-
SVA Proteins Counteract DDX23 via Caspase-Dependent Apoptosi
2026-05-01
This study uncovers how Senecavirus A (SVA) manipulates host antiviral defense by targeting the DEAD-box helicase DDX23 through distinct apoptotic pathways. By mapping critical viral and host protein interactions, the research highlights new molecular targets that could inform antiviral strategy development.
-
Z-IETD-FMK: Precision Caspase-8 Inhibition for Apoptosis Res
2026-05-01
Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) sets a new benchmark in dissecting caspase-8-dependent apoptosis and immune signaling. This article delivers actionable workflows, troubleshooting strategies, and advanced use-case insights—empowering researchers to leverage APExBIO’s inhibitor for robust, reproducible results in immune cell activation and TRAIL-mediated apoptosis studies.
-
Tirbanibulin Suppresses Oncogenic Pathways in HPV+ HeLa Cell
2026-04-30
This study demonstrates that tirbanibulin markedly reduces proliferation and downregulates oncogenic protein expression in HPV-18 positive HeLa cells. Through dose-dependent inhibition of the Src-MEK-ERK pathway and HPV oncoproteins E6/E7, tirbanibulin reveals mechanistic targets for therapeutic intervention in HPV-associated malignancies.
-
Disulfiram: Advanced Workflows in Cancer and Proteasome Rese
2026-04-30
Disulfiram, a clinically proven dopamine β-hydroxylase inhibitor, has become an indispensable research tool for inducing apoptotic cancer cell death and dissecting proteasomal pathways. This article demystifies its experimental workflows and offers expert troubleshooting strategies, with actionable links between recent mechanistic insights and real-world laboratory use.
-
Refining In Vitro Drug Response Assays in Cancer Research
2026-04-29
Schwartz's dissertation critically examines how traditional in vitro assays can obscure the distinct effects of anti-cancer drugs on cell proliferation and death. By dissecting the metrics of relative and fractional viability, the study advances methodological clarity for evaluating agents like JNJ-26854165 (Serdemetan) in preclinical cancer research.
-
Doxorubicin Hydrochloride: Protocols and Troubleshooting in
2026-04-29
Doxorubicin hydrochloride (Adriamycin HCl) remains the cornerstone of cancer chemotherapy research, offering robust DNA damage modeling and cardiotoxicity exploration. This guide delivers actionable workflow enhancements, troubleshooting strategies, and new insights on mitigating doxorubicin-induced toxicity, equipping scientists with best-in-class experimental tools.
-
Z-YVAD-FMK: Caspase-1 Inhibitor Workflows for Apoptosis & Py
2026-04-28
Z-YVAD-FMK empowers precise dissection of caspase-1-mediated cell death pathways, enabling robust apoptosis, pyroptosis, and inflammasome research. This article delivers workflow enhancements, troubleshooting tips, and protocol insights—supported by current literature and APExBIO’s trusted expertise.
-
Practical Use of FITC-Concanavalin A (ConA) Conjugate in Car
2026-04-28
FITC-Concanavalin A (ConA) Conjugate offers a direct, fluorescence-based solution for detecting α-D-glucose and α-D-mannose residues on cell surfaces, supporting immunofluorescence and flow cytometry workflows. It should be used strictly within its defined stability and storage limits, and is not suitable for non-carbohydrate binding or cross-domain applications.
-
SM-164: Decoding Apoptosis Beyond Transcriptional Inhibition
2026-04-27
Explore how SM-164, a bivalent Smac mimetic, advances apoptosis research by illuminating the interplay between IAP antagonism and RNA Pol II-independent cell death. Gain unique mechanistic and assay design insights for cancer research.
-
Disulfiram: Synthetic Lethality and Proteasome Inhibition in
2026-04-27
This article explores the evolving role of Disulfiram as a dopamine β-hydroxylase inhibitor and copper-complexed proteasome inhibitor, emphasizing its translational potential in cancer research. Highlighting recent evidence on synthetic lethality in APC-deficient colorectal cancer and mechanistic insights in breast cancer, we provide strategic guidance for researchers pursuing novel apoptotic pathways and resistance-breaking therapies.